Cypress Bioscience, Inc. (CYPB)

Cypress Bioscience, Inc. is related to 2 other symbols. To date we've encountered 4 releases involving Cypress Bioscience, Inc..

Last Price: 5.31 (+0.24) - 12/2/2008, 4:00pm

• Open: 5.16
• High: 5.35
• Low: 5.01

Cypress Bioscience, Inc. Options

• Cypress Bioscience, Inc. "Business Partners"
• Cypress Bioscience, Inc. Press Releases
• Cypress Bioscience, Inc. News
• Cypress Bioscience, Inc. Contact
• Cypress Bioscience, Inc. Related (via TRYNT)

Cypress Bioscience, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Cypress Bioscience, Inc..

• CDNS
• OMTR

^

Cypress Bioscience, Inc. Press Releases

• Cypress Bioscience, Inc.: Cypress Bioscience, Inc. to Present at UBS Global Life Sciences Conference (Trackbacks) (Backlinks), Mon, 25 Sep 2006 3:30:00 PDT

  SAN DIEGO, CA (MARKET WIRE) Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006.

• Cypress Bioscience: Pilot Trials in Obstructive Sleep Apnea Completed (Trackbacks) (Backlinks), Tue, 27 Jun 2006 11:56:00 PDT

  SAN DIEGO, CA (MARKET WIRE) Cypress Bioscience Inc. (NASDAQ: CYPB) announced today that results of recently completed Phase IIa trials do not support continuing a development program evaluating combinations of mirtazapine with another approved drug as potential pharmaceutical treatments for obstructive sleep apnea (OSA).

• Cypress Bioscience: Pilot Trials in Obstructive Sleep Apnea Completed (Trackbacks) (Backlinks), Tue, 27 Jun 2006 5:37:00 PDT

  SAN DIEGO, CA (MARKET WIRE) Cypress Bioscience Inc. announced today that results of recently completed Phase IIa trials do not support continuing a development program evaluating combinations of mirtazapine with another approved drug as potential pharmaceutical treatments for obstructive sleep apnea (OSA).

• Cypress Bioscience Inc.: Cypress Bioscience Inc. to Present at Jefferies Life Sciences Conference (Trackbacks) (Backlinks), Fri, 23 Jun 2006 3:30:00 PDT

  SAN DIEGO, CA (MARKET WIRE) Cypress Bioscience Inc. (NASDAQ: CYPB) today announced that Sabrina Martucci Johnson, its Chief Business Officer and Chief Financial Officer, will present at the Jefferies Life Sciences Conference on Tuesday, June 27, 2006.

^

Cypress Bioscience, Inc. News

• Healthcare Stock Opportunities In a Down Market (at Seeking Alpha), Sat, 22 Nov 2008 18:18:15 Etc/GMT
• CYPRESS BIOSCIENCE INC Financials (EDGAR Online Financials), Sat, 15 Nov 2008 14:04:18 Etc/GMT
• New Star Analyst Rankings for Cypress Bioscience, Inc. (StarMine), Tue, 11 Nov 2008 14:24:35 Etc/GMT
• CYPRESS BIOSCIENCE INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online), Mon, 10 Nov 2008 11:35:15 Etc/GMT
• Cypress Bioscience, Inc. Announces Third Quarter 2008 Results (Marketwire), Mon, 10 Nov 2008 11:30:00 Etc/GMT
• Backlog of Decisions Is Building at the FDA (at Seeking Alpha), Sat, 8 Nov 2008 18:43:03 Etc/GMT
• Cypress Bioscience, Inc. to Present at Oppenheimer 19th Annual Healthcare Conference (Marketwire), Fri, 31 Oct 2008 10:30:00 Etc/GMT
• 60 Defensive Growth Stocks (at Seeking Alpha), Sun, 26 Oct 2008 09:02:10 Etc/GMT
• Six Healthcare Stocks at Sale Prices (at Seeking Alpha), Sun, 26 Oct 2008 08:51:44 Etc/GMT
• Cypress Bioscience Launches Two New Personalized Medicine Services for Rheumatologists (Marketwire), Fri, 24 Oct 2008 12:00:00 Etc/GMT
• In Two Days, Four New Drugs Stall at FDA (at The Wall Street Journal Online), Wed, 22 Oct 2008 13:42:00 Etc/GMT
• FDA Action Before Year End (at Seeking Alpha), Tue, 21 Oct 2008 20:00:08 Etc/GMT
• CYPRESS BIOSCIENCE INC Files SEC form 8-K, Regulation FD Disclosure (EDGAR Online), Mon, 20 Oct 2008 17:48:11 Etc/GMT
• Forest, Cypress face delay in FDA drug review (AP), Mon, 20 Oct 2008 13:25:25 Etc/GMT
• FDA Defers Final Action on milnacipran New Drug Application (PR Newswire), Mon, 20 Oct 2008 12:00:00 Etc/GMT
• Ride The Ups And Downs Of Drug Approval (at Investopedia), Thu, 16 Oct 2008 21:13:23 Etc/GMT
• Potential Short Trades on Pending FDA Decisions (at Seeking Alpha), Mon, 13 Oct 2008 11:04:35 Etc/GMT
• Wall Street Media Presents Exclusive Videos from the JMP Healthcare Focus Conference (Business Wire), Wed, 8 Oct 2008 19:01:00 Etc/GMT
• Coverage initiated on Cypress Biosci by RBC Capital Mkts (Briefing.com), Tue, 7 Oct 2008 12:12:59 Etc/GMT
• Cypress Bioscience Could Be a Buy Given Upcoming FDA Decision (at Seeking Alpha), Mon, 6 Oct 2008 08:13:41 Etc/GMT

^

Cypress Bioscience, Inc. Contact

• For more information, please contact:
  For Cypress Bioscience:
  Sabrina Martucci Johnson
  Chief Financial Officer
  Mary Gieson
  Investor Relations
  Tel. +1 (858) 452-2323
  
  

TRYNT Related

• TRYNT did not suggest any related symbols

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.